We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Herman Miller's (MLHR) Q2 Earnings?
Read MoreHide Full Article
Herman Miller, Inc. is slated to report second-quarter fiscal 2020 results on Dec 18, after the bell.
The company has an impressive earnings surprise history, having surpassed the Zacks Consensus Estimate in all of the trailing four quarters with a positive surprise of 7.1%, on average.
The stock has gained 57.9% year to date, significantly outperforming the 35.6% growth of the industry it belongs to.
Expectations This Time Around
The Zacks Consensus Estimate for revenues in the to-be-reported quarter stands at $694.8 million, indicating year-over-year growth of 6.5%.
The top line is likely to have benefited from strength in the company’s Retail segment. Growth in the HAY brand, Design Within Reach contract business, new studios and outlet stores is expected to have driven the segment. In first-quarter fiscal 2020, revenues rose 7.4% year over year to $671 million.
The consensus estimate for earnings is pegged at 87 cents, indicating year-over-year growth of 16%. Improved production leverage, lower steel prices and benefits from ongoing profit enhancement initiatives are expected to have benefited the bottom line. In the first quarter of fiscal 2019, adjusted earnings rose 21.7% from the year-ago quarter to 84 cents.
What Our Model Says
Our proven Zacks model does not conclusively predict an earnings beat for Herman Miller this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Herman Miller has an Earnings ESP of 0.00% and a Zacks Rank #3.
Here are a few stocks that investors may consider as our model shows that these have the right combination of elements to beat on second-quarter fiscal 2020 earnings:
Worthington Industries, Inc. (WOR - Free Report) has a Zacks Rank of 3 and an Earnings ESP of +5.78%. The company will report results on Dec 17.
Cintas Corporation (CTAS - Free Report) has a Zacks Rank of 3 and an Earnings ESP of +2.02%. The company will report results on Dec 17.
General Mills, Inc. (GIS - Free Report) has an Earnings ESP of +1.58% and a Zacks Rank #3. The company will report results on Dec 18.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
Image: Bigstock
What's in Store for Herman Miller's (MLHR) Q2 Earnings?
Herman Miller, Inc. is slated to report second-quarter fiscal 2020 results on Dec 18, after the bell.
The company has an impressive earnings surprise history, having surpassed the Zacks Consensus Estimate in all of the trailing four quarters with a positive surprise of 7.1%, on average.
The stock has gained 57.9% year to date, significantly outperforming the 35.6% growth of the industry it belongs to.
Expectations This Time Around
The Zacks Consensus Estimate for revenues in the to-be-reported quarter stands at $694.8 million, indicating year-over-year growth of 6.5%.
The top line is likely to have benefited from strength in the company’s Retail segment. Growth in the HAY brand, Design Within Reach contract business, new studios and outlet stores is expected to have driven the segment. In first-quarter fiscal 2020, revenues rose 7.4% year over year to $671 million.
Herman Miller, Inc. Revenue (TTM)
Herman Miller, Inc. revenue-ttm | Herman Miller, Inc. Quote
The consensus estimate for earnings is pegged at 87 cents, indicating year-over-year growth of 16%. Improved production leverage, lower steel prices and benefits from ongoing profit enhancement initiatives are expected to have benefited the bottom line. In the first quarter of fiscal 2019, adjusted earnings rose 21.7% from the year-ago quarter to 84 cents.
What Our Model Says
Our proven Zacks model does not conclusively predict an earnings beat for Herman Miller this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Herman Miller has an Earnings ESP of 0.00% and a Zacks Rank #3.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to Consider
Here are a few stocks that investors may consider as our model shows that these have the right combination of elements to beat on second-quarter fiscal 2020 earnings:
Worthington Industries, Inc. (WOR - Free Report) has a Zacks Rank of 3 and an Earnings ESP of +5.78%. The company will report results on Dec 17.
Cintas Corporation (CTAS - Free Report) has a Zacks Rank of 3 and an Earnings ESP of +2.02%. The company will report results on Dec 17.
General Mills, Inc. (GIS - Free Report) has an Earnings ESP of +1.58% and a Zacks Rank #3. The company will report results on Dec 18.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>